Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Markets often climb despite worries. In 2020, markets rose before economic recovery. Now, in 2026, markets are recovering amid geopolitical...

MOFSL Chairman Raamdeo Agrawal advises investors to prioritize survival during the current West Asia conflict, which he finds harder to pre...

Every other nation in the world has centrally planned and funded Covid immunisation. India alone favours a diametrically opposite model, es...

Serum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine 'Covishield' to Rs 300 per dose from the earlier ...

Pricing has been left to the vaccine makers, except for the proviso that it must be declared in advance. The price meant for sale to privat...

The endeavour by Infosys, Wipro and Tech Mahindra—among the largest private employers in India—comes days after the government opened up co...

Worldwide, half a billion vaccine doses have been administered. While shots have been given in some 140 countries, the vast majority have g...

The amount to be paid by people opting to be vaccinated at private hospitals is under discussion, and will be decided by the health ministr...

The Central Drugs Standard Control Organisation (CDSCO), will take up their applications for consideration on Wednesday. Three vaccine cand...

To meet that demand, pharma companies, which are working on the potential vaccine candidate for Covid-19, have started tying up with manufa...

The pricing announcement comes as Russia looks to scale up distribution and production. Kirill Dmitriev, head of Russia's RDIF sovereign we...

Disclosing this in Hyderabad on Monday, managing director Mahima Datla said the company is currently evaluating four different formulations...

"Our plan is to be able to ship vaccines to the immunization sites within 24 hours of approval" by the US Food and Drug Administration, Mon...

"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of U...